ARTICLE | Clinical News
Sutent sunitinib regulatory update
December 13, 2010 8:00 AM UTC
The European Commission approved a label expansion for Sutent sunitinib to include treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumors with disease progressio...